EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

High‐Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study

Ryota Sagami iD, Kentaro Yamao iD, Akinori Shimizu, Hidefumi Nishikiori, Koji Yoshida, Akihiro Yoshida, Mamoru Takenaka iD, Hajime Imai, Katsunori Sekine, Masatoshi Murakami iD, Nao Fujimori iD, Rintaro Nagayama und 9 weitere

United European Gastroenterology Journal · 2026-11 · 14 (9)

DOI: 10.1002/ueg2.70329 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 15.11.2026. Verfasst von Ryota Sagami und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Early Detection of Cancer. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To prospectively evaluate the diagnostic performance of a structured scoring system integrating multiple pancreatic cancer (PC)–relevant factors for detecting early‐stage PC among clinically selected outpatients.

Methods

In this nationwide multicenter prospective cohort study, consecutive physician‐selected outpatients undergoing initial endoscopic ultrasonography for mild symptoms, risk factors, or subtle imaging abnormalities were enrolled. Risk factors were categorized as low‐ or high‐grade relevance (LGR/HGR), with one point per factor. A positive score was defined as LGR ≥ 3 and/or HGR ≥ 1. Diagnostic performance for high‐grade dysplasia (HGD)/stage 1 PC was compared with that of conventional symptom‐, family history‐, and genetic risk‐based approaches within this cohort.

Results

Among 3269 patients, 2525 were score‐positive and 744 were score‐negative. For HGD/stage 1 PC, the sensitivity, specificity, positive predictive value, and negative predictive value were 93.2%, 23.1%, 2.7%, and 99.3%, respectively. Sensitivity significantly exceeded that of conventional approaches (93.2% vs. 56.8%, p < 0.001), although paired comparison using the conditional relative odds ratio (CROR) showed no significant difference (CROR, 1.79; 95% CI, 0.54–5.90; p = 0.34). HGD/stage 1 PC detection was significantly higher in score‐positive than in score‐negative patients (2.7% vs. 0.7%, p = 0.001). Among PCs detected in score‐positive patients, 24.3% were HGD/stage 1.

Conclusions

The scoring system demonstrated high cross‐sectional sensitivity for HGD/stage 1 PC detection among clinically selected outpatients undergoing detailed PC evaluation. Its utility for selecting patients from unselected general outpatient populations remains unestablished. Prospective validation in consecutive general outpatients with systematic longitudinal follow‐up is warranted. Trial Registration This study was registered in the University Hospital Medical Network Clinical Trials Registry ( http://www.umin.ac.jp/ctr/index.htm ) as UMIN000034832 on December 1, 2018

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsEarly Detection of CancerHumansFemaleMaleProspective StudiesMiddle AgedAgedSensitivity and SpecificityRisk FactorsEndosonographyPredictive Value of TestsNeoplasm StagingOutpatientsAdult

Stichwörter der Autor:innen

diagnostic performancehigh‐grade dysplasiapancreatic ductal adenocarcinomascoring systemscreening

Autor:innen und Institutionen

  • Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan.
  • Department of Advanced Gastrointestinal Cancer Medicine, Faculty of Medicine, Oita University, Oita, Japan.
  • Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Department of Gastroenterology, Onomichi General Hospital, Hiroshima, Japan.
  • Department of Gastroenterology, Oita San-ai Medical Center, Oita, Japan.
  • Department of Gastroenterology and Hepatology, Kawasaki Medical School, Okayama, Japan.

ORCID-Profile: Ryota Sagami, Kentaro Yamao, Mamoru Takenaka, Masatoshi Murakami, Nao Fujimori, Jun Nakahodo, Kazuhiro Mizukami, Kazunari Murakami, Keiji Hanada

Zitieren

APA

Sagami, R., Yamao, K., Shimizu, A., Nishikiori, H., Yoshida, K., Yoshida, A., Takenaka, M., Imai, H., Sekine, K., Murakami, M., Fujimori, N., Nagayama, R., Ueki, T., Nakahodo, J., Okamoto, K., Kinoshita, M., Takayama, Y., Amano, Y., Mizukami, K., …, & Hanada, K. (2026). High‐Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study. United European Gastroenterology Journal, 14(9). https://doi.org/10.1002/ueg2.70329

Vancouver

Sagami R, Yamao K, Shimizu A, Nishikiori H, Yoshida K, Yoshida A, et al. High‐Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study. United European Gastroenterology Journal. 2026;14(9). doi:10.1002/ueg2.70329

BibTeX
@article{Sagami2026,
  author = {Sagami, Ryota and Yamao, Kentaro and Shimizu, Akinori and Nishikiori, Hidefumi and Yoshida, Koji and Yoshida, Akihiro and Takenaka, Mamoru and Imai, Hajime and Sekine, Katsunori and Murakami, Masatoshi and Fujimori, Nao and Nagayama, Rintaro and Ueki, Toshiharu and Nakahodo, Jun and Okamoto, Kazuhisa and Kinoshita, Makiko and Takayama, Yukiko and Amano, Yuji and Mizukami, Kazuhiro and Murakami, Kazunari and Hanada, Keiji},
  title = {High‐Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study},
  journal = {United European Gastroenterology Journal},
  year = {2026},
  volume = {14},
  number = {9},
  doi = {10.1002/ueg2.70329}
}
Kostenlos starten →